• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    'Most Suspicious Congressional Stock Trade?' Little-Known Med Tech Firm Surges 48% In Just 2 Months After Senator Tina Smith Bought The Dip

    12/28/23 3:16:33 AM ET
    $AORT
    $TCMD
    Medical/Dental Instruments
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $AORT alert in real time by email

    Sen. Tina Smith’s (D-Minn.) significant November investment in a medical device maker’s stock has yielded a remarkable 48% return within just two months. 

    What Happened: Smith purchased $250,000 worth of healthcare company Tactile Systems Technology (NASDAQ:TCMD) shares, a move labeled as “the most suspicious congressional stock trade in months” by Quiver Quantitative on social media. 

    UPDATE$TCMD is now up 48% in the two months since Senator Smith made this trade.

    Ridiculous.

    Any politician who profits this much off a stock that they directly oversee should be required to put their money in a blind trust. pic.twitter.com/qeqGwjuV8A

    — Quiver Quantitative (@QuiverQuant) December 26, 2023

    The value of TCMD stock, standing at about $10 at the time of investment, increased to $14.85 by the market’s closing on Nov. 27, with a subsequent rise of 4.79% over the past 30 days.

    Being a member of the Senate Committees on Health and the firm being based in her home state of Minnesota adds to the intrigue. The company has secured several government contracts worth millions of dollars despite its relatively small size. 

    The timing of the investment coincided with a significant downturn in TCMD’s stock market value. 

    Since Smith’s investment, the company’s stock value has surged by a remarkable 48%. 

    This isn’t the only successful trade by Smith, as she also invested in Artivion (NYSE:AORT) around the same time, yielding similarly profitable results. 

    See Also: ‘Dogecoin Killer’ Shiba Inu Witnesses Record Withdrawal: 8 Trillion Tokens Exit Exchanges Since November

    Why It Matters: This incident raises concerns amid the ongoing scrutiny of Congressional stock trading, fueling support for the "Ban Congressional Stock Trading Act," a bipartisan bill seeking to prohibit representatives from directing their investments. 

    Despite growing support, the vote for the bill has been repeatedly delayed. TCMD’s current value, lower than its yearly highs, notably began climbing after Senator Smith’s investment, following a sharp fall. 

    Nancy Pelosi, the former House Speaker, is known for her involvement in stock trading, to the extent that there exists a tracker for her portfolio. The stock acquisitions made by her spouse frequently face scrutiny, particularly in light of the regulatory information she has access to.

    Read Next: Jeff Bezos Was Time Magazine’s Person Of The Year In 1999: If You Invested $1000 In Amazon Then…

    Image created using photos on Shutterstock

    Get the next $AORT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AORT
    $TCMD

    CompanyDatePrice TargetRatingAnalyst
    Artivion Inc.
    $AORT
    4/10/2026$42.00Neutral → Buy
    Ladenburg Thalmann
    Tactile Systems Technology Inc.
    $TCMD
    1/5/2026$35.00Neutral → Overweight
    Piper Sandler
    Tactile Systems Technology Inc.
    $TCMD
    11/4/2025$28.00Neutral → Buy
    BTIG Research
    Tactile Systems Technology Inc.
    $TCMD
    10/3/2025$23.50Buy
    Lake Street
    Artivion Inc.
    $AORT
    8/13/2025$38.79Buy → Neutral
    Ladenburg Thalmann
    Artivion Inc.
    $AORT
    6/17/2025$35.00Buy
    Canaccord Genuity
    Tactile Systems Technology Inc.
    $TCMD
    5/6/2025$14.00Overweight → Neutral
    Piper Sandler
    Tactile Systems Technology Inc.
    $TCMD
    2/19/2025$23.00 → $18.00Buy → Neutral
    B. Riley Securities
    More analyst ratings

    $AORT
    $TCMD
    SEC Filings

    View All

    SEC Form DEFA14A filed by Artivion Inc.

    DEFA14A - ARTIVION, INC. (0000784199) (Filer)

    4/1/26 4:19:38 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    SEC Form DEF 14A filed by Artivion Inc.

    DEF 14A - ARTIVION, INC. (0000784199) (Filer)

    4/1/26 4:18:50 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Tactile Systems Technology Inc.

    SCHEDULE 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    3/27/26 1:17:04 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    May 23, 2023 - FDA Roundup: May 23, 2023

    For Immediate Release: May 23, 2023 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  On Monday, the FDA and the Veterans Health Administration announced a new collaboration to jointly develop emergency preparedness and response tools and protocols intended to help increase medical product manufacturing capacity and flexibility, and improve resilie

    5/23/23 4:06:19 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Semedo Anthony B. bought $53,140 worth of shares (2,100 units at $25.30), increasing direct ownership by 4% to 35,659 units (SEC Form 4)

    4 - ARTIVION, INC. (0000784199) (Issuer)

    3/5/25 4:01:01 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Artivion Announces U.S. FDA Approval of the NEXUS® Aortic Arch System

    Endospan's NEXUS branched endovascular stent graft system shown to effectively treat aortic arch disease, including chronic aortic dissectionsATLANTA, April 7, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE:AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration (FDA) has approved the premarket approval application (PMA) for the NEXUS® Aortic Arch System, developed by Endospan Ltd. ("Endospan"), Artivion's long-standing partner. The approval entitles Artivion to exercise its option to acquire Endospan at any time within 90 days of receiving this notice of FDA approval. Artivion has a $150 million delayed draw term

    4/7/26 7:00:00 AM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    Neuronetics Reports Fourth Quarter and Full Year 2025 Financial and Operating Results

    Total revenue of $41.8 million in Q4 2025, up 86% as reported and 23% on an adjusted pro forma basis versus Q4 2024 Greenbrook clinic revenue of $23.5 million in Q4 2025, up 428% as reported and 37% on an adjusted pro forma basis versus Q4 2024 Continued cash management improvement, with cash provided by operations of $0.9 million in Q4 2025 Expect full year 2026 revenue of between $160 million and $166 million Dan Reuvers appointed as President and Chief Executive Officer, effective March 23, 2026; proven medical device leader with more than 30 years of experience scaling commercial healthcare businesses MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc., (NASDAQ:STIM

    3/17/26 7:50:00 AM ET
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Artivion upgraded by Ladenburg Thalmann with a new price target

    Ladenburg Thalmann upgraded Artivion from Neutral to Buy and set a new price target of $42.00

    4/10/26 8:27:02 AM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    Tactile Systems upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Tactile Systems from Neutral to Overweight and set a new price target of $35.00

    1/5/26 8:37:29 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Systems upgraded by BTIG Research with a new price target

    BTIG Research upgraded Tactile Systems from Neutral to Buy and set a new price target of $28.00

    11/4/25 7:20:09 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Tactile Systems Technology Inc.

    3 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

    3/11/26 4:13:02 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Director Pearson Andrea was granted 852 shares (SEC Form 4)

    4 - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Issuer)

    3/11/26 4:13:53 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    VP, Chief Accounting Officer Horton Amy sold $34,036 worth of shares (901 units at $37.78) and was granted 7,475 shares, increasing direct ownership by 5% to 139,088 units (SEC Form 4)

    4 - ARTIVION, INC. (0000784199) (Issuer)

    3/4/26 6:54:39 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Financials

    Live finance-specific insights

    View All

    Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

    MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Summary: Total revenue increased 21% year-over-year to $103.6 millionGross margin of 78% versus 75% in Q4 2024Net income of $10.6 million versus $9.7 million in Q4 2024Adjusted EBITDA of $22.9 million versus $16.2 million in Q4 2024 Full Year 2025 Summary: Total revenue increased 12% year-over-year to $329.5 millionGross margin of 76%, compared to 74% in 2024Oper

    2/17/26 4:05:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical Acquires LymphaTech, Expanding Breadth and Depth of its Lymphedema Solutions Portfolio

    MINNEAPOLIS, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that it has acquired LymphaTech Inc., for an upfront cash payment at closing of $6.8 million, plus potential additional consideration that is contingent upon the achievement of future milestones. Founded in 2014, LymphaTech, Inc. is a privately held medical technology company pioneering a digital, three-dimensional ("3D") full body measurement and monitoring platform designed specifically for lymphedema. Damage to the lymphatic system from chronic fluid accumulat

    2/17/26 4:04:00 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Artivion Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter Highlights: GAAP revenue was $116.0 million in the fourth quarter of 2025 versus $97.3 million in the fourth quarter of 2024. For the full year, GAAP revenue was $441.3 million versus $388.5 million for the full year of 2024. GAAP net income was $2.4 million, or $0.05 per fully diluted share, in the fourth quarter of 2025, versus a net loss of $(16.5) million, or $(0.39) per fully diluted share in the fourth quarter of 2024. For the full year 2025, GAAP net income was $9.8 million, versus a net loss of $(13.4) million for the full year 2024.Adjusted revenue1 was $118.3 million in the fourth quarter of 2025, an increase of 18% on an adjusted constant currency basis compared to

    2/12/26 4:05:00 PM ET
    $AORT
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Leadership Updates

    Live Leadership Updates

    View All

    Neuronetics Appoints Dan Reuvers as President and Chief Executive Officer

    MALVERN, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM) (the "Company"), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker of NeuroStar® Advanced Therapy, today announced the appointment of Dan Reuvers as the Company's next President and Chief Executive Officer, effective March 23, 2026. Mr. Reuvers will also join the Board of Directors at that time. He succeeds Keith Sullivan, who will step down as the Company's President and Chief Executive Officer on March 23, 2026 and retire on March 31, 2026 after five and a half years of leadin

    3/17/26 7:45:00 AM ET
    $IART
    $STIM
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical Strengthens Board of Directors with Appointment of Andrea Pearson

    MINNEAPOLIS, March 09, 2026 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical"; the "Company") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Andrea Pearson to the Company's Board of Directors ("Board") and as a member of the Compliance & Reimbursement and Nominating & Corporate Governance Committees, effective March 9, 2026. Ms. Pearson is an accomplished senior executive and growth strategist with deep expertise in scaling healthcare organizations. Her extensive experience spans more than 25 years and includes exposure to product development, customer acquisition, branding, market

    3/9/26 8:00:00 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    Tactile Medical Appoints Laura King to Board of Directors

    MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. ("Tactile Medical") (NASDAQ:TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company's Board of Directors ("Board") and as a member of the Audit and Compliance & Reimbursement Committees, effective January 13, 2025. Ms. King is a seasoned healthcare executive with a proven track record of leadership and developing innovative products that enhance patient care. Her extensive experience includes a 22-year career at General Electric Company (GE), where she served as a Company Officer in her role as President & CEO of GE

    1/13/25 8:00:00 AM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    $AORT
    $TCMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Tactile Systems Technology Inc.

    SC 13G/A - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/13/24 7:29:11 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Tactile Systems Technology Inc.

    SC 13G - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/13/24 5:04:27 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Tactile Systems Technology Inc.

    SC 13G - TACTILE SYSTEMS TECHNOLOGY INC (0001027838) (Subject)

    11/8/24 3:21:42 PM ET
    $TCMD
    Medical/Dental Instruments
    Health Care